Pharmacogenomics Hub in a strengthened IMGGE

Project Information

PharmGenHUB

Grant agreement ID: 101059870

DOI

10.3030/101059870

Project closed

EC signature date 6 April 2022

Start date 1 July 2022

End date 30 June 2025

Funded under

• Widening participation and spreading excellence

Total cost

€ 1 339 250,00

EU contribution

€ 1 339 250,00

Coordinated by

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Serbia

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (8)

First report on the bioinformatics trainings at UPAT
Strengthened transferable and soft skills of the IMGGE staff
Setting up a RMU at IMGGE

RMU will be set up at the kickoff meeting M1 by appointing staff from IMGGE

First report on the human iPSC-based model system trainings at UNITS

First report on the human iPSCbased model system trainings at UNITS

Plan for dissemination, exploitation and communication (kick-off meeting)

Initial plan for dissemination exploitation and communication

Kick-off meeting report and naming the Project Management Board and Advisory Board

Kickoff meeting report and naming the Project Management Board and Advisory Board

First report on the advanced statistics trainings at UL
Data management plan (Kick-off meeting)

Data management plan initial following Kickoff meeting

Websites, patent fillings, videos etc. (2)

Interactive web site

Interactive web site will be created where information regarding the aims of the Project progress in achieving goals and relevant supporting will be available at all times and updated monthly from month 6 The web site will be also accessible through IMGGE web site wwwimggebgacrs and will be bilingual Serbian and English languages

Leaflets containing information on significance and clinical use of pharmacogenomics markers.

Leaflets containing information on significance and clinical use of pharmacogenomics markers Three leaflets are planned

Publications

Peer reviewed articles (3)

Comprehensive pharmacogenomics profiling of the Serbian population

Author(s): Marina Jelovac, Djordje Pavlovic, Biljana Stankovic, Nikola Kotur, Bojan Ristivojevic, Sonja Pavlovic, Branka Zukic
Published in: Frontiers in Pharmacology, Issue 16, 2025, ISSN 1663-9812
Publisher: Frontiers Media SA
DOI: 10.3389/FPHAR.2025.1553536

The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity

Author(s): Debora Curci, Biljana Stankovic, Nikola Kotur, Letizia Pugnetti, Vladimir Gasic, Maurizio Romano, Branka Zukic, Giuliana Decorti, Gabriele Stocco, Marianna Lucafò, Sonja Pavlovic
Published in: Frontiers in Pharmacology, Issue 15, 2024, ISSN 1663-9812
Publisher: Frontiers Media SA
DOI: 10.3389/FPHAR.2024.1448136

The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress

Author(s): van Schaik RH, Manolopoulos VG, Daly AK, Niemi M, Zukic B, Patrinos GP, Primorac D, Swen JJ, Ingelman-Sundberg M, Morris T, Molden E, Müller D, Pavlovic S, Russmann S, Ansari M, Henricks LM, den Broek WV, Florindi F, Bozina N, Akin D, Christrup L, Llerena
Published in: Pharmacogenomics, Issue 24(5), 2023, ISSN 1462-2416
Publisher: Ashley Publications Ltd.
DOI: 10.2217/PGS-2023-0013